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ABSTRACT Suramin, a polysulfonated naphthylurea, is under investigation for the treatment of several cancers. It interferes
with signal transduction through Gs, Gi, and Go, but structural and kinetic aspects of the molecular mechanism are not well
understood. Here, we have investigated the influence of suramin on coupling of bovine rhodopsin to Gt, where G-protein
activation and receptor structure can be monitored by spectroscopic in vitro assays. Gt fluorescence changes in response to
rhodopsin-catalyzed nucleotide exchange reveal that suramin inhibits Gt activation by slowing down the rate of complex
formation between metarhodopsin-II and Gt. The metarhodopsin-I/-II photoproduct equilibrium, GTPase activity, and nucle-
otide uptake by Gt are unaffected. Attenuated total reflection Fourier transform infrared spectroscopy shows that the structure
of rhodopsin, metarhodopsin-II, and the metarhodopsin-II Gt complex is also not altered. Instead, suramin dissociates Gt from
disk membranes in the dark, whereas metarhodopsin-II Gt complexes are stable. Fo¨rster resonance energy transfer suggests
a suramin-binding site near Trp207 on the Gt subunit (Kd0.5 M). The kinetic analyses and the structural data are consistent
with a specific perturbation by suramin of the membrane attachment site on Gt. Disruption of membrane anchoring may
contribute to some of the effects of suramin exerted on other G-proteins.
INTRODUCTION
Suramin, a hexasulfonated polyaromatic naphthylurea (1.4
kDa), is under study for therapeutic activity in phase II trials
in the treatment of several cancers (Mirza et al., 1997;
Dawson et al., 1998; Dreicer et al., 1999). It exhibits anti-
angiogenetic and antiproliferative activity (Firsching et al.,
1995) by interfering with the binding of several growth
factors to their receptors (Coffey et al., 1987). These prop-
erties can be enhanced in suramin analogs (Gagliardi et al.,
1998). However, adverse effects of suramin are dose-limit-
ing (Chaudhry et al., 1996), and the molecular basis of its
action is not well understood. The function of several cel-
lular signaling proteins, such as protein-tyrosine phospha-
tases (Zhang et al., 1998) and protein kinase C (Khaled et
al., 1995) is perturbed, and recent interest in suramin fo-
cuses on its ability to interfere also with signaling through
G-protein-coupled receptors (GPCRs). GPCRs are heptahe-
lical transmembrane proteins that respond to extracellular
signals, such as binding of a hormone or a neurotransmitter,
by catalyzing GDP/GTP exchange in cytosolic guanosine-
nucleotide-binding proteins (G-proteins) (for reviews see Ji
et al., 1998; Gether, 2000). Suramin has been shown to
uncouple 2- and 2-adrenergic receptors from Gi and Gs,
respectively (Huang et al., 1990). It has also been shown
that suramin inhibits activation of pertussis-toxin-sensitive
G-proteins by -opioid receptors in NG 108–15 cell mem-
branes, whereas nucleotide exchange induced by serum
factors binding to an unidentified receptor was not affected
(Butler et al., 1988). Based on these initial observations, the
potential of suramin analogs to interfere with signaling by
different receptor G-protein tandems has been investigated
systematically. A suramin analog has been described that
uncouples A1 adenosine and D2 dopamine receptors from
Gi/Go with different specificity (Beindl et al., 1996; Wald-
hoer et al., 1998), and a number of analogs have been
synthesized that act as subtype-specific G-protein inhibitors
(Hohenegger et al., 1998; Waldhoer et al., 1998). Such
studies emphasize the role of G-proteins as potential drug
targets (Ho¨ller et al., 1999). However, details of the molec-
ular mechanism by which suramin affects structural and
kinetic parameters of receptor G-protein interactions remain
to be elucidated. In an attempt to exploit a well character-
ized in vitro model system for GPCR signaling, we have
investigated the effect of suramin on activation of transdu-
cin (Gt) by the bovine photoreceptor rhodopsin. For this
system, biophysical assays for conformational changes of
the receptor, Gt binding, and Gt activation are available.
Based on the homology of class I (rhodopsin-like) GPCRs,
a study of the action of suramin on rhodopsin Gt interactions
helps to identify molecular mechanisms by which the drug
may affect signaling in related systems.
Rhodopsin is a prototypical GPCR (Helmreich and Hof-
mann, 1996; Menon et al., 2001; Okada et al., 2001) and the
only one for which a crystal structure has been solved
(Palczewski et al., 2000). Rhodopsin is unique as it is not
ligand-activated. Instead, 11-cis-retinal is covalently at-
tached to Lys296 of the apoprotein via a protonated Schiff
base (Oseroff and Callender, 1974). Photoisomerization to
all-trans-retinal promotes structural changes involving he-
lix-helix interactions and rigid body movements (Farrens et
al., 1996; Han et al., 1996; Sheikh et al., 1996). As a
consequence, cytosolic domains of the active metarhodop-
sin-II (MII) state bind Gt and catalyze GDP/GTP exchange.
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Signaling by the rhodopsin Gt tandem has been optimized
for maximal light sensitivity, which implies minimization of
dark noise (Birge and Barlow, 1995; Rieke and Baylor,
1996). Correspondingly, basal nucleotide exchange, typical
of other G-proteins, is negligible in Gt. The unique features
of rhodopsin and Gt suggest that interference with receptor
coupling is the predominant mode of action by which a
pharmacologically active substance may modulate Gt acti-
vation. Other potential perturbations such as interference
with basal G-protein activation or competition with agonist
binding are not expected to contribute to the readout from
this model system.
We have applied fluorescence spectroscopy to analyze
binding of suramin to Gt and to monitor rhodopsin-cata-
lyzed Gt activation. By attenuated total reflection (ATR)
Fourier transform infrared (FTIR) spectroscopy we have
investigated the influence of suramin on the structure of
rhodopsin and the MIIGt complex. We show that suramin
binds to Gt but does not affect either GTP uptake or
GTPase activity. Likewise, structural changes during rho-
dopsin activation are not influenced. Instead, the rate of
MIIGt formation is reduced by a dose-dependent inhibition
of membrane anchoring of Gt. In addition to inferences on
receptor G-protein coupling in nonvisual signaling, the data
are relevant for the molecular characterization of side ef-
fects on vision in patients receiving suramin treatment. A
variety of ocular symptoms have been described (for exam-
ple, Hemady et al., 1996).
MATERIALS AND METHODS
Purification of rhodopsin and transducin
Preparation of washed membranes from bovine rod outer segments (ROSs)
was carried out as described (Papermaster, 1982) with minor modifica-
tions. Gt was purified from illuminated, osmotically shocked ROSs by
successive washes and hexyl agarose chromatography (Ku¨hn, 1980; Fung
et al., 1981). Gt was eluted with 300 mM NaCl in buffer solution (10 mM
sodium phosphate, pH 7.2, 2 mM MgCl2, 1 mM dithiothreitol (DTT), 0.1
mM phenylmethylsulfonyl fluoride). Pooled fractions were diluted with
buffer to a final concentration of 100 mM NaCl. Gt and Gt were isolated
from Gt (prepared from bovine retinas, Lawson, Lincoln, NE) according to
published methods (Shichi et al., 1984) using a Hitachi LC-organizer
high-performance liquid chromatography system with 1 ml of Hi-Trap
Blue Sepharose column (Amersham Pharmacia Biotech, Piscataway, NJ).
The proteins were eluted with a 0–2 M NaCl gradient. Protein concentra-
tions were determined using the Bio-Rad protein assay reagent according
to manufacturer’s instructions. The subunits were stored at 20°C in a
50% glycerol buffer until use.
ATR-FTIR spectroscopy
Disk membranes (1–2 nmol of rhodopsin) were dried under nitrogen on a
trapezoidal (45°) internal reflection element (IRE) made of ZnSe (3.5 cm2)
mounted in a Bruker A737 temperature-controlled dialysis-coupled
(10,000 MW cutoff) ATR cell. Under these conditions, membrane stacks of
at least 50 layers are expected to form, when the surface coverage by
rhodopsin in disk membranes is estimated from the crystal structure (Pal-
czewski et al., 2000) to be 1500 Å2. Thus, more than 98% of rhodopsin
is excluded from possible denaturing influences of the ZnSe surface and
the functionality (normal light-dependent MII formation and Gt activation)
of the resulting matrix of immobilized disk membranes has been demon-
strated (Fahmy, 1998).
After addition of Gt (0.5–1 ml, 4–6 M, 10 mM sodium phosphate
buffer, pH 7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT) to the sample
compartment, its association with disk membranes was monitored in a
vector 22 FTIR spectrophotometer (Bruker, Karlsruhe, Germany). GTP,
suramin, and heparin were purchased from Sigma-Aldrich (Milwaukee,
WI) and used without further purification. Dissociation of Gt from disk
membranes was induced by addition of the appropriate amounts of these
substances to the dialysis reservoir of the ATR cell. Subsequent spectral
changes were measured as the difference between the absorption (calcu-
lated from 256 interferograms) at a given time after and the absorption
immediately before the addition of either substance. Experiments were
carried out at 17°C. Light-induced IR absorption changes during metar-
hodopsin II (MII) formation in the absence of Gt were measured at 10°C
(10 mM sodium phosphate buffer, pH 5, 100 mM NaCl, 30 s illumi-
nation with 150-W projector light using a GG 495 filter from Schott,
(Mainz, Germany).
Fluorescence measurements
GTP-induced changes of tryptophan fluorescence from Gt were recorded
with a home-built instrument, using fiber optics attached to a temperature-
controlled cuvette holder for excitation and emission in 90° geometry.
Excitation was achieved with UV light from a deuterium lamp equipped
with an interference filter transmitting 290–310-nm light (300FS10–25,
L.O.T. Oriel, Darmstadt, Germany). Emitted light (max  345 nm) was
detected by a photomultiplier after transmission through a 335-nm cutoff
filter (WG 335 Schott). Integration time of the fluorescence signals was 4 s
and the reaction mixture was continuously stirred by a magnetic stir bar in
a quartz cuvette. A suspension of disk membranes in buffer containing 1–2
M Gt was photoactivated 5 min before starting fluorescence recordings.
The reaction mixture (0.8 ml) was thermostatted to 27°C.
FRET from suramin to Gt was measured in a Spex Fluorolog 3–11 3
spectrofluorometer equipped with a 450-W xenon arc lamp. Excitation was
at 295 nm, and emission was recorded between 315 and 450 nm. The
fluorescence spectra were recorded in 10 mM Tris buffer (pH 7.2), 100
mM NaCl, 2 mM MgCl2, 1 mM DTT, 5 M GDP, and 0.01% dodecyl
maltoside.
Data analysis
Kinetic fluorescence data were fitted by numerical integration of rate
equations using the Newton method. In a two-step reaction model, the time
derivative of the concentration of the GTP-bound state of Gt was assumed
to depend on the rate constants k1 and k2, describing formation of Gt(GTP)
from Gt(GDP) and GTP (catalyzed by MII) and decay of Gt(GTP) to
Gt(GDP) and Pi by intrinsic GTPase activity of Gt, respectively:
d[Gt(GTP)]/dt	 k1
 [Gt(GDP)]
 [GTP]
k2[Gt(GTP)] (1)
Microscopic rate constants for the formation of MIIGt as well as for GDP
release were not explicitly included. Instead, the concentration of MIIGt
was implicitly defined in proportion to the concentration of Gt(GDP).
In a more realistic three-step model, the formation of the MIIGt com-
plex from MII and Gt(GDP) and uptake of GTP (followed by immediate
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dissociation of the MIIGt complex) was described by the rate constants kc
and ku, respectively:
d[MIIGt]/dt	 kc
 [MII]
 [Gt(GDP)]
ku  [MIIGt]
 [GTP] (2)
d[Gt(GTP)]/dt	 ku  [MIIGt]  [GTP]
kh  [Gt(GTP)], (3)
where kh is the rate constant for GTP hydrolysis. In contrast to the two-step
model, the rate of MIIGt formation, rather than its concentration, is pro-
portional to the concentration of Gt(GDP) in the three-step model. This
leads to a superior simulation when MIIGt formation becomes rate limiting.
Data on FRET from Gt to suramin were analyzed to determine the
fraction f(Gt) of free Gt in the presence of varying amounts of suramin
according to Eq. 4:
f(Gt)  (FS  Fq)/(F0  Fq), (4)
where Fs, Fq, and F0 is the tryptophan fluorescence in the presence of a
given suramin concentration, at maximal concentration of suramin, and in
the absence of suramin, respectively. The right side of Eq. 4 was deter-
mined from peak emission values at 343 nm. These were corrected for
inner filtering by suramin absorption at the excitation and emission wave-
length as described (Pigault and Ge´rard, 1984) using absorption coeffi-
cients of 20,500 and 9,440 M1 cm1 at 295 and 343 nm, respectively.
Absorption and fluorescence spectra of suramin have been published (Me´ly
et al., 1997; Zhang et al., 1998).
RESULTS
Fluorescence monitoring of Gt activation
To investigate the action of suramin on receptor-dependent
G-protein signaling, we have designed experiments using
the bovine photoreceptor rhodopsin and Gt as a model
system. Rhodopsin-catalyzed nucleotide exchange and GTP
hydrolysis by Gt were monitored with a real-time Gt acti-
vation assay (Fahmy and Sakmar, 1993; Ernst et al., 2000)
based on intrinsic G-protein fluorescence (Higashijima et
al., 1987). The fluorescence increases of Trp207 of
Gt(GTP) or Gt(GTPS) versus Gt(GDP) (Faurobert et
al., 1993) allow the observation of nucleotide uptake and
hydrolysis during multiple cycles of Gt activation. Fig. 1
shows fluorescence recordings from Gt in a suspension of
light-activated disk membranes. Repeated addition of GTP
caused transient fluorescence increases corresponding to the
increase of [Gt(GTP)] followed by a decrease due to GT-
Pase activity of Gt. The traces evidence the catalytical
nature of the Gt turnover and the stability of rhodopsin Gt
interactions during the time of the experiment. Addition of
a saturating amount of the nonhydrolyzable GTP analog
GTPS caused a persistent fluorescence increase. The de-
crease in fluorescence upon further addition of GTPS as
well as the fluorescence signal reached at the end of GTP-
induced signals scaled precisely with the corresponding
dilution of the reaction buffer.
The described assay allows an accurate evaluation of the
kinetics of rhodopsin Gt coupling. The peak height and
width of the GTP-induced transients is determined by the
apparent rate of the rising and falling phase of [Gt(GTP)].
The peak height (normalized to the GTPS-induced signal)
decreased whereas the peak width increased as a function of
suramin concentration. This indicates that suramin caused
an increase of the apparent fluorescence rise time. In prin-
ciple, the effect of suramin may be accounted for by dena-
turing Gt or rhodopsin. However, the more thorough quan-
titative analysis of reaction kinetics as well as spectroscopic
data, presented below, strongly suggest that the data in Fig.
1 must be explained by a specific inhibitory effect of
suramin on the MII-dependent formation of Gt(GTP).
FIGURE 1 Influence of suramin on nucleotide-dependent fluorescence
changes of Gt ([GTP] [Gt]). Arrows indicate injection of GTP (1.4 M)
and GTPS (6 M) to a reaction mixture (10 mM sodium phosphate, pH
7.2, 100 mM NaCl, 2 mM MgCl2, 1 mM DTT) containing photoactivated
rhodopsin (150 nM) in suspension of disk membranes and freshly prepared
Gt (1.8 M). Experiments were carried out at 27°C. Bars delimit identical
areas under each trace when normalized to the size of the respective
GTPS-induced fluorescence increase. (A) Fluorescence signals in the
absence of suramin. The curve drawn through the first GTP-induced signal
was calculated according to Eq. 1 with k1  0.147 M
1s1 and k2 
0.059 s1. For the simulation of the GTPS-induced signal, k2 was set to
zero. (B) Fluorescence signals at 3 M suramin (initial fluorescence 90%
of that in A). (C) Fluorescence signals at 12 M suramin (initial fluores-
cence 67% of that in A). The first GTP-induced signal has been fitted
according to Eq. 1 with k1  0.100 s
1 and k2  0.058 s
1. The same
transient as well as the GTPS-induced signal was replotted to the right in
a scale in which the GTPS-induced signal is normalized to that in A, to
better appreciate the normalized peak area of the GTP-induced signal (see
text for details). (D) Fluorescence signals at 24 M suramin (initial
fluorescence 50% of that in A). The curve drawn through the GTPS-
induced signal was calculated as in A, but k1 was reduced by a factor of
0.14 (k2  0.0 s
1).
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For a given rate of GTP hydrolysis, the area under the
transient fluorescence signal is a measure of the amount of
GTP hydrolyzed. Because identical aliquots of GTP were
injected in all experiments, the peak area is not expected to
depend on the presence of suramin if the drug exclusively
influenced the formation of MIIGt. Integration intervals and
baseline positions for GTP-induced peaks are represented
by the length and vertical position, respectively, of the bars
in Fig. 1. In trace A, the baseline was determined by the
fluorescence level at the end of the transient. In traces B–D,
baselines were adjusted to obtain identical normalized peak
areas as in trace A. The correspondence of normalized areas
under GTP-induced signals is exemplified in panel C, where
the GTP-induced transient has been replotted in a scale in
which the GTPS-induced signal (shown to the right)
matches that in A. Evidently, the criterion of invariant peak
areas yields excellent agreement with the measured traces.
Thus, an effect of suramin on GTPase activity is negligible
within the accuracy of the experiment.
Estimates of the apparent rate constants k1 and k2 for GTP
uptake and hydrolysis, respectively, can be obtained in the
realm of a two-step reaction model described by Eq. 1. The
larger k1/k2, the higher is the fluorescence peak. For each
peak, k1/k2 assumes well defined values that were used to
generate the curves drawn through the data in Fig. 1. All
fluorescence traces are well described by the two-step
model. The influence of suramin can be accounted for by a
successive reduction of k1 at a constant value of k2. This
agrees with the model-independent evaluation of peak ar-
eas. At all suramin concentrations tested, the data could be
fitted with hydrolysis rates of 0.044 s1  k2  0.059 s
1,
which is in agreement with the range of reported hydrolysis
rates (Yamanaka et al., 1985; Antonny et al., 1993; Otto-
Bruc et al., 1994) and renders unlikely denaturation of Gt by
suramin. In contrast, k1 had to be reduced by factors of 0.85,
0.52, 0.38, and 0.14 in the presence of 3, 6, 12, and 24 M
suramin, respectively, relative to its value in the absence of
suramin. Therefore, a pronounced influence is exerted on
the reaction(s) that lead to uptake of GTP by Gt, whereas an
effect of suramin on GTP hydrolysis (k2) must be small, if
it is present at all. The drop in k1 for Gt activation with
GTPS (k2  0) parallels that for activation with GTP. For
example, the GTPS-induced signal at 24 M suramin (Fig.
1 D) is approximated by the model when k1 is reduced by
the same factor (0.14) that was used for the simulation of the
GTP-induced signal.
In the measurements shown in Fig. 1, where [GTP] 
[Gt], the reaction mixture had become depleted of GTP
before a steady state was reached during which GTP hydro-
lysis can approximately balance the formation of Gt(GTP).
At higher [GTP], a nearly constant fraction of Gt(GTP)
was present before the pool of nucleotide was eventually
turned over. This resulted in a broadening of the fluores-
cence signal that cannot be reproduced by the two-step
reaction model. Fluorescence time courses with [GTP] 
[Gt] (Fig. 2) were analyzed in a more realistic model (Eqs.
2 and 3) to assess specifically the influence of suramin on
MIIGt formation (kc) and GTP uptake (ku). The values for ku
and kh in the absence of suramin were held constant and
only kc was varied. In an iterative process, a pair of rate
constants ku and kh was found that allowed simultaneous fits
of reasonable quality to all traces. At constant rates of ku of
0.14 M1 s1 and kh of 0.031 s
1, kc was reduced by
factors of 0.43, 0.3, and 0.12 at 2.5, 5.0, and 10.0 M
suramin, respectively, relative to its value of 0.7 M1 s1
in the absence of suramin. [GTP] was increased by 18% at
10 M suramin (Fig. 2 D) to extend the steady state during
which [Gt(GTP)] was only slowly changing. In contrast to
the two-step model, the three-step model is clearly able to
FIGURE 2 Influence of suramin on nucleotide-dependent fluorescence
changes of Gt ([GTP]  [Gt]). Injection of GTP (2.5 M (A–C), 3.1 M
(D)) to a reaction mixture containing photoactivated rhodopsin (130 nM) in
suspension of disk membranes and freshly prepared Gt (1 M). Experi-
mental conditions are as given in Fig. 1. The scale bar corresponds to 50%
of the GTPS-induced signal. (A–D) Fluorescence signals in the absence
and presence of 2.5, 5.0, and 10.0 M suramin, respectively. Solid lines are
numerical solutions of rate equations (Eqs. 2 and 3) using ku  0.14
M1s1 and kh of 0.031 s
1 for all traces, whereas kc was reduced by
factors of 0.43, 0.3, and 0.12 relative to its value of 0.7 M1s1 in the
absence of suramin. Additional thin lines in traces C and D are results from
simulations in which kc and kh were fixed (at 0.7 M
1s1 and 0.031 s1,
respectively) at both suramin concentrations, whereas ku was 0.06
M1s1 and 0.026 M1s1 at 5 and 10 M suramin, respectively.
(E–G) Fluorescence changes induced by injection of GTP (2.5 M) fol-
lowed by GTPS (6 M) in the presence of heparin (7.5, 15.0, and 30.0
mg/L, respectively) measured in parallel with traces B–D in reaction
mixtures made from identical stocks.
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describe this situation. The rate constants for MIIGt associ-
ation and GTP hydrolysis in the absence of suramin are of
the correct magnitude (Schleicher and Hofmann, 1987; Ya-
manaka et al., 1985; Antonny et al., 1993; Otto-Bruc et al.,
1994), and we conclude that suramin acts primarily on kc.
The additional curves in Fig. 2, C and D (thin lines) were
obtained by exclusively adjusting ku. Obviously, the shape
of the resulting time courses is incorrectly described, par-
ticularly at high suramin concentrations. This supports a
specific action of suramin on MIIGt formation while other
molecular processes on the Gt activation/deactivation path-
way can proceed normally. In control experiments (Fig. 2,
E–G) in which heparin was substituted for suramin, the
fluorescence changes were not affected, ruling out a general
polyanionic effect on Gt activation. In summary, the kinetic
analyses reveal that suramin slows down the light-depen-
dent activation of Gt by reducing the rate of MIIGt complex
formation, whereas GTP uptake and GTP hydrolysis is not
affected.
Fluorescence energy transfer from Gt
to suramin
The reduction of both basal Gt fluorescence and the GTPS-
induced fluorescence increase indicates that suramin binds
to Gt, thereby quenching its tryptophan fluorescence. The
nucleotide-dependent fluorescence change of Trp207 was
more affected than basal fluorescence. For example, basal
fluorescence at 24 M suramin was reduced by 50%,
whereas the GTPS-induced fluorescence change was re-
duced by 70% (Fig. 1, A and D). Quenching of Gt fluo-
rescence was further analyzed by fluorescence emission
spectroscopy. When excited at 295 nm, Gt fluorescence is
maximal at 343 nm. With increasing suramin concentration,
fluorescence at this wavelength decreased while emission
from suramin above 400 nm increased (Fig. 3 A). At low
suramin concentrations and 240 nM Gt, appearance of
suramin fluorescence was barely visible, whereas an isos-
bestic point formed at 377 nm at suramin concentrations
above 0.5 M. The spectra indicate that Gt and suramin
form a donor-acceptor pair undergoing FRET with spectral
features almost identical with those described for other
suramin-binding proteins (Me´ly et al., 1997; Zhang et al.,
1998). At 480 nM Gt, formation of an isosbestic point at
416 nm for suramin concentrations below 0.5 M was
reproducibly observed (Fig. 3 B). The decrease of Gt
fluorescence between 10 and 53 M suramin and the con-
comitant increase of suramin fluorescence above 400 nm
suggest that suramin binds to Gt with a Kd  10 M.
However, the insets in Fig. 3 show that the fraction of free
Gt (Eq. 4) was barely changing above 5 M suramin when
corrected for absorption of excitation and emission light by
suramin (see Materials and Methods). The corrected data
reveal that suramin binds to Gt with a Kd of 0.5 M,
typical of suramin binding to other G-proteins (Freissmuth
et al., 1996). The fluorescence increase above 400 nm
observed between 10 and 53 M suramin was thus due to
free suramin, and the decrease of tryptophan emission was
caused by absorption of excitation light by suramin. This
was expected as the amount of suramin exceeded that of Gt
by a factor of 40–200, implying preponderance of free
suramin. Likewise, the upshift of the apparent isosbestic
point at [suramin] 0.5 M from 377 nm to 390 nm at 240
and 480 nM Gt, respectively, is entirely consistent with
stronger tryptophan emission bands in Fig. 3 B versus A
superimposed with directly excited fluorescence from free
suramin.
Influence of suramin on the structure of
rhodopsin, MII, and MIIGt and on membrane
anchoring of Gt
In addition to binding to Gt, reduced Gt activation may be
caused by suramin shifting the MI/MII equilibrium toward
the inactive MI species. However, UV-visible absorption
changes did not show an absorption increase in the 460–
FIGURE 3 Fo¨rster resonance energy transfer from Gt to suramin. So-
lutions of purified Gt (10 mM Tris, pH 7.2, 100 mM NaCl, 2 mM MgCl2,
1 mM DTT, 5 M GDP) were excited at 295 nm and emission measured
from 315 to 450 nm. (A and B) Gt concentration was 240 and 480 nM,
respectively. Suramin concentrations (from top to bottom) were 0.0, 0.25,
0.5, 0.74, 0.99, 1.23, 3.70, 6.14, 11.00, 20.58, 29.98, and 52.69 M. Insets
show the saturation of fluorescence quenching corrected for inner filtering
by suramin (Materials and Methods) and for dilution (13%) upon con-
secutive addition of aliquots from suramin stock solutions. Experiments
were carried out at 27°C.
Coupling of Rhodopsin to Transducin 797
Biophysical Journal 82(2) 793–802
480-nm range (MI) at the expense of decreased 380-nm
absorption (MII, not shown). We have addressed more
subtle effects of suramin on the conformation of rhodopsin,
MII, and MIIGt by ATR-FTIR spectroscopy. Light-induced
conformational changes in rhodopsin are accompanied by
characteristic shifts in the frequencies of vibrational modes
of the structurally affected parts of the protein backbone,
amino acid side chains, and the retinal chromophore as
reviewed in Siebert (1995). Consequently, light-induced
FTIR difference spectra allow the detection of perturbations
of the normal structural changes during MII formation. In
contrast to transmissive FTIR spectroscopy, the ATR-FTIR
technique applied here monitors absorption changes of disk
membranes adsorbed on an internal reflection element
(IRE) in the presence of a bulk aqueous phase. In addition
to structural changes, shifts in the binding equilibrium be-
tween Gt or suramin in the aqueous phase and in disk
membranes give rise to IR-absorption changes as the
amount of absorbing species in the evanescent field of the
IRE (extending 1 m from its surface) is affected. IR
absorption changes during MII formation at pH 5 are shown
in Fig. 4 (negative bands are caused by the dark state, and
positive bands correspond to absorption by MII). Except for
a small additional positive band at 1040 cm1, typical of
suramin (Fig. 4 E), no alterations were observed in the
difference spectrum recorded at 50 M suramin (Fig. 4 B)
versus normal MII formation (Fig. 4 A), although GTP-
induced fluorescence signals were completely abolished at
this concentration. At 500 M suramin (Fig. 4 C), the
light-induced absorption increase at 1040 cm1 was larger,
and additional alterations occurred in the amide I and II
spectral range. These were identified by subtracting the
normal MII difference spectrum from that measured in the
presence of 500 M suramin, resulting in the spectrum
shown in Fig. 4 D. The flat baseline obtained between 1700
and 1800 cm1 demonstrates that the CAO stretching vi-
brations of Asp83 (1767()/1747()), Glu113 (1711()),
and Glu122 (1727()/1747()) (Fahmy et al., 1993; Rath et
al., 1993; Ja¨ger et al., 1994) were not altered. This confirms
that the reduction of Gt activation cannot be attributed to a
stabilizing effect of suramin on the MI state. A shift in the
MI/MII equilibrium would have led to residual bands be-
tween 1700 and 1800 cm1 (Fahmy, 1998) caused by pro-
tonated Glu122 and by protonation of Glu113 in MII. The
absorption at 1040 cm1 and the bands between 1400 and
1000 cm1 correspond well with absorption by free suramin
(Fig. 4 E) and indicate binding of suramin to photoactivated
disk membranes. The alterations at 1650 and 1545 cm1
may indicate an effect on the structure of dark rhodopsin at
500 M suramin (i.e., in excess of serum concentrations of
suramin in patients (Chaudhry et al., 1996)); however, the
band at 1643 cm1, typical of the Gt activating conforma-
tion of MII (Fahmy et al., 1994; Zvyaga et al., 1996), was
not affected. In conclusion, the FTIR difference spectra
argue against structural perturbations of rhodopsin or MII
by suramin in the low micromolar range.
To study the influence of suramin on the structure of
MIIGt, Gt was added to disk membranes in the dark. Bind-
ing of Gt is accompanied by characteristic absorption in-
creases in the amide I (1610–1700 cm1) and II (1510–
1580 cm1) frequency range (Fig. 5 A) as Gt accumulates in
the evanescent field of the IRE. The functionality of MII Gt
interactions under the conditions of the ATR-FTIR experi-
ment has been demonstrated (Fahmy, 1998). After illumi-
nation, suramin was added by dialysis and ensuing absorp-
tion changes were recorded. Appearance of the drug in the
evanescent field was evidenced by the sharp absorption
increase at 1040 cm1 (Fig. 5 B). In the amide I and II
frequency range, slight absorption increases were observed
as well and may have been caused by the amide groups in
suramin or additional binding of Gt. More importantly, no
negative bands occurred. Such bands are expected when
FIGURE 4 Light-induced ATR-FTIR spectra of rhodopsin. (A–C) Ab-
sorption changes typical of MII formation in the absence of suramin and at
50 and 500 M suramin, respectively. Photoproduct bands show upwards,
and absorption bands of the dark state are negative. Experiments were
carried out at 10°C in buffer (10 mM sodium phosphate, pH 5, 100 mM
NaCl) with disk membranes adsorbed on an IRE made of ZnSe. (D)
Suramin-induced spectral changes in the MII difference spectra obtained
by subtraction of trace A from trace C. (E) Infrared absorption of 60 mM
suramin in H2O, measured by ATR-FTIR.
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suramin caused denaturation of MIIGt, thereby shifting vi-
brational frequencies of structurally affected peptide bonds.
If suramin causes conformational changes in MIIGt at all,
they must be smaller than those accompanying the light-
dependent formation of MII or MIIGt, as these would
clearly be visible as sharp superimposed difference bands of
1–3 mAU in the amide I/II range (Fahmy, 1998). Likewise,
suramin does not dissociate MIIGt. As shown in Fig. 5 C,
dissociation of MIIGt upon addition of nucleotide is not
prevented either. GTPS was added to the dialysis compart-
ment in a higher concentrated sodium phosphate buffer,
providing a monitor of the buffer exchange by the absorp-
tion increase of inorganic phosphate at 1077 and 988 cm1.
The loss of amide absorption of Gt coincided with the onset
of absorption by inorganic phosphate, indicating that Gt
dissociated from disk membranes with the arrival of the
GTPS-containing buffer in the evanescent field. The ATR-
FTIR results suggest that the reduction of the apparent rate
of Gt(GTP) formation as determined by the Gt activation
assay is caused neither by a shift in MI/MII equilibrium nor
by altered structures of MII/MIIGt, nor by occupation of the
GTP-binding site by suramin.
To test the influence of suramin on steps before MIIGt
formation, Gt was allowed to bind to disk membranes in the
dark (Fig. 6 A) and suramin was added without prior photo-
activation. With the arrival of suramin in the evanescent field
(1040 cm1 absorption increase) amide I and II absorption of
Gt decreased. This demonstrates that suramin promoted disso-
ciation of Gt from disk membranes. At 20 M and 100 M
suramin, 60% and 85% of Gt absorption was lost from the
membranes, respectively. In a control experiment in which
suramin was replaced by 3-kDa heparin no loss of absorption
by Gt was observed (Fig. 6, D and E). In summary, the
ATR-FTIR data indicate that suramin exerts its effect on sig-
naling by rhodopsin through a loss of membrane affinity of Gt
rather than by affecting the structure of rhodopsin, MII, MIIGt,
or occupation of the GTP-binding site of Gt.
FIGURE 5 ATR-FTIR spectra induced by suramin and GTPS in Gt-
loaded disk membranes in the light. (A) Binding of Gt (10 mM sodium
phosphate, pH 7.2, 150 mM NaCl, 2 mM MgCl2, 1 mM DTT) in the dark
to disk membranes. (B) Spectral changes accompanying dialysis of 30 M
suramin into the sample compartment after illumination (30 s with 150-W
slide projector through GG495 Schott filter). (C) Spectral changes evoked
by dialysis over 2, 5, and 15 min of 500 M GTPS and 20 mM sodium
phosphate into the sample compartment. Spectral changes were calculated
with respect to reference spectra recorded immediately before buffer ex-
change in the dialysis compartment. Experiments were carried out at 17°C.
FIGURE 6 ATR-FTIR spectral changes during association of Gt with
disk membranes in the dark followed by suramin-induced dissociation. (A)
Absorption increase after binding of Gt to disk membranes in the dark. (B)
and (C) Absorption decrease induced by dissociation of Gt from mem-
branes upon dialysis of 20 and 100 M suramin, respectively, into the
sample compartment. (D) Binding of Gt to disk membranes in an indepen-
dent experiment. (E) Absorption changes during subsequent dialysis of
3-kDA heparin (100 M) into the sample compartment. Experimental
conditions as given in Fig. 5.
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DISCUSSION
The influence of suramin on coupling of
Gt to rhodopsin
We have demonstrated that pharmacologically relevant con-
centrations of suramin affect activation of Gt by bovine
rhodopsin. This has made possible an analysis of the mech-
anism by which suramin acts on G-protein signaling in a
well characterized in vitro model system. Kinetic analyses
of Gt activation demonstrate that suramin affects coupling
of Gt to MII but alters neither the rate of nucleotide uptake
nor GTP hydrolysis. Likewise, neither the MI/MII equilib-
rium nor the structure of rhodopsin and MIIGt is altered by
suramin at concentrations that abolish Gt activation. Instead,
the rate of association of Gt with MII is reduced.
MIIGt formation exhibits a fast component attributable to
efficient collisions between MII and membrane-bound Gt
and a slow component for the transition of Gt from a free to
a disk-membrane-bound form (Schleicher and Hofmann,
1987). As membrane association is the rate-limiting step,
the influence of suramin can be explained by inhibition of
Gt binding to photoactivated disk membranes. The molec-
ular processes underlying this transition may be very similar
to or identical with those during association of Gt with
membranes in the dark. Thus, suramin-induced dissociation
of Gt from disk membranes in the dark, evidenced by
ATR-FTIR, may be directly related to the mechanism by
which MIIGt formation is impaired under conditions of
multiple activation cycles. Because membrane anchoring of
Gt is mediated by Gt (Seitz et al., 1999), it is likely that
suramin perturbs the membrane attachment site on Gt.
Binding of suramin to Gt is evidenced by FRET and is
characterized by a Kd of 0.5 M. The evaluation of Gt
activation rates is in general agreement with this Kd. Even in
the realm of a simplified reaction model, including only
GTP uptake and hydrolysis, half-maximal inhibition oc-
curred at 6 M suramin, whereas 3 M would be expected
from the estimated Kd of 0.5 M (conditions of the exper-
iment shown in Fig. 1). In a more realistic three-step model,
50% reduction of the rate constant for MIIGt complex
formation was observed at 2.5 M suramin concentration.
This agrees precisely with 50% saturation of suramin-bind-
ing sites with a Kd of 0.5 M (conditions of the experi-
ment shown in Fig. 2) and strongly suggests that suramin
binds in a 1:1 stoichiometry to Gt as reported for binding
to Gs (Hohenegger et al., 1998). Half-maximal dissociation
of Gt from disk membranes measured by ATR-FTIR spec-
troscopy occurred at higher suramin concentration (10–20
M). Taking into account the different experimental con-
ditions, the concentrations for half-maximal effects of
suramin in both assays appear to be very similar. Therefore,
our data suggest that 1) occupation of a single suramin-binding
site on Gt with Kd of 0.5 M is the predominant cause for
the inhibition of rhodopsin-catalyzed Gt activation, and 2) the
rate of complex formation between suramin-bound Gt and MII
is specifically impaired by a reduced affinity of suramin-bound
Gt for photoreceptor membranes.
Reduction of membrane affinity of Gt by suramin may
involve electrostatic repulsion of suramin-bound Gt (car-
rying six negative extra charges) from disk membranes
and/or interference with the exposure of the N-terminal acyl
chains. Results from SDS-PAGE of supernatants of Gt-
containing solutions (3 M) equilibrated in the dark with
disk membranes agree with a reduced membrane affinity of
Gt in the presence of suramin (data not shown). The same
holds for binding of Gt to electrically neutral phosphatidyl-
choline vesicles, rendering likely a specific effect on lipid
anchoring. The topology of the suramin-binding site on Gt
needs further investigation, but one of the two chro-
mophoric 1,3,6-naphthalenetrisulfonate (NTS) moieties
may bind near Trp207. This is suggested by the suramin-
dependent reduction of nucleotide-induced fluorescence
changes of Gt known to arise from Trp
207. Although bind-
ing of suramin to nucleotide-binding sites has been de-
scribed for other proteins (van Rhee et al., 1994; Khaled et
al., 1995), the different elution properties of nucleotides
versus suramin (Figs. 5 and 6) and the unaltered rate con-
stant for nucleotide uptake consistently disfavor binding to
the nucleotide-binding site of Gt. Electrostatic interactions
between NTS and positively charged amino acids have been
inferred from the solution structure of NTS-bound acidic
fibroblast growth factor (Lozano et al., 1998) and may be
crucial for binding of NTS to Gt as well. Preliminary dock-
ing simulations using the program FlexX provided by the
Gesellschaft fu¨r Mathematische Datenanalyse (Bonn, Ger-
many), also resulted in highest-scoring solutions for binding
of NTS to Gt (Protein Data Bank entry 1TAD) in positions
within less than 3 Å from the positively charged guani-
dinium groups of Arg201 and Arg204 and 10–15 Å apart
from Trp207. We suspect that the drug approaches the N-
terminus of Gt where it may interfere with membrane
anchoring (Matsuda et al., 1994; Seitz et al., 1999) and may
additionally affect electrostatically driven steps during re-
ceptor recognition (Fanelli et al., 1999).
Comparison with the action of suramin on other
receptor G-protein tandems
Structural and functional properties are probably conserved
among members of each class of GPCRs. Two modes of
action of suramin on Gs-, Gi-, and Go-dependent signaling
by class I (rhodopsin-like) GPCRs have been described.
One mode is the reduction of basal nucleotide exchange at
submicromolar to micromolar concentrations of suramin.
We have shown here that suramin binds to Gt in a 1:1
stoichiometry as reported for other G-proteins (Hohenegger
et al., 1998) and with a Kd that falls in the same range as the
EC50 for suppression of basal nucleotide exchange. How-
ever, Gt does not exhibit receptor-independent nucleotide
exchange. Correspondingly, the rhodopsin Gt model system
800 Lehmann et al.
Biophysical Journal 82(2) 793–802
was not expected to respond to this particular mode of
suramin action. Another mode of suramin action is uncou-
pling from the receptor (Beindl et al., 1996). We have
demonstrated that inhibition of rhodopsin-dependent Gt ac-
tivation does indeed occur. It has been shown for Gs that
suramin binds not only to epitopes involved in receptor
recognition but also overlaps with effector binding sites
(Freissmuth et al., 1996). Trp207 in Gt is near switch II of
Gt and thus close to regions that bind to the effector (Berlot
and Bourne, 1992; Rarick et al., 1992). Binding of suramin
to that region would also be consistent with the preferential
quenching of fluorescence from Trp207. Finally, binding of
suramin to Gi/Gs has been shown to cause dissociation of the
ternary complex with agonist-bound receptors (Beindl et al.,
1996). Because the agonist of rhodopsin, all-trans retinal, is
covalently bound, an analogous action of suramin was not
expected in this system, and dissociation of MIIGt was not
observed. This parallels the quasi-competitive behavior of
suramin with respect to agonist as increasing receptor occu-
pancy could reverse the destabilizing effect of suramin on the
ternary complex of ligand-activated receptors.
The action of suramin on signaling by other G-protein
-subunits appears to be paralleled by its action on Gt
when the unique features of this system are taken into
account. Our data further suggest that inhibition of re-
ceptor-catalyzed G-protein activation may operate
through a reduced membrane affinity of suramin-bound
G-protein -subunits. Binding to membranes is primarily
mediated by G-palmitoylation and to a less extent by
N-terminal myristoylation (as reviewed in Wedegaertner
et al., 1995; Milligan and Grassie, 1997). Gt is not
palmitoylated and may be particularly sensitive to desta-
bilization of membrane anchoring via a single N-terminal
acylation. However, G-protein palmitoylation is a dy-
namic process. For example, palmitate turnover on Gs in
S49 cells has been shown to become accelerated upon
-adrenergic receptor activation (Wedegaertner and
Bourne, 1994). Therefore, the acylation state and, corre-
spondingly, the membrane affinity of other G-subunits
may transiently correspond with that of Gt.
CONCLUSIONS
Rhodopsin Gt interactions may constitute a versatile in vitro
model system to elucidate the action of suramin-related
drugs on G-protein-dependent signaling. Furthermore, our
results hint at a possible adverse effect on scotopic vision in
patients receiving suramin treatment. Constant monitoring
of dosage in these patients is important because of toxic
effects of suramin. A putative impairment of rhodopsin-
mediated dim light vision by suramin needs further inves-
tigation as it may correlate with other adverse effects that
need to be controlled in clinical studies.
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